Skip links

LISRAYA™ (brepocitinib)

Full Name LISRAYA™ (brepocitinib)
Drug brepocitinib
Manufacturer Priovant Therapeutics
Route of Administration Oral
Site of Care Home
Approved Indication The treatment of dermatomyositis in adult patients
Disease Dermatomyositis
Therapeutic Area Rheumatology, Neurology, Dermatology
Phone Number 847-453-3265
Fax Number 877-471-5764
Enrollment Form Link Enrollment Form
Product Website lisrayahcp.com